Technical advances in sequencing methods and instruments are rapidly transforming our ability to study both common and rare genetic variants in the human genome. Indeed, several human genomes have already been sequenced in their entirety [1] [2] [3] [4] . However, for the time being, the cost for sequencing whole human genomes is prohibitive for addressing research questions in a large cohort of individuals.
A r t i c l e s
Technical advances in sequencing methods and instruments are rapidly transforming our ability to study both common and rare genetic variants in the human genome. Indeed, several human genomes have already been sequenced in their entirety [1] [2] [3] [4] . However, for the time being, the cost for sequencing whole human genomes is prohibitive for addressing research questions in a large cohort of individuals.
Three approaches are currently being used for enrichment of target sequences of interest. The first approach is traditional singleplex PCR, which has been used for hundreds of samples to examine large kilobase-sized contiguous intervals 5 or the exons of hundreds of genes 6, 7 . Although traditional PCR enriches target sequences with high specificity and sensitivity, it is difficult to scale the method to match the throughput of current sequencing instruments.
The second approach is based on multiplex amplification of thousands of target sequences in a single tube by array-synthesized padlock 'molecular inversion' probes [8] [9] [10] . Molecular inversion probes allow for a highly efficient multiplex reaction owing to the tethering of primer pairs by a DNA linker. However, published results show that although the captures are highly specific and represent upwards of 90% of the targets, there is >100-fold range in coverage of the targeted sequences, and 34-42% of sequence capacity is consumed by either sequencing of primer sequences or the molecular inversion probes' linker backbone 9 (Supplementary Discussion).
The third approach, based on hybridization with long oligonucleotides that are either matrix-bound or in solution, captures and pulls down the target sequences [11] [12] [13] [14] . The hybridization-based methods have good capture rates, uniform coverage of target sequences and good reproducibility. However, the methods are known to be biased to repetitive elements, which can result in a high proportion of reads that map nonuniquely. Additionally, sequences that are highly homologous to other sequences in the genome cannot be individually targeted.
We have developed an approach, involving microdroplet-based technology, which takes advantage of the high specificity and sensitivity of PCR and allows for massively parallel singleplex amplification of complex target sequences. The discrete encapsulation of microdroplet PCR reactions prevents possible primer pair interactions, allowing for highly efficient simultaneous amplification of up to 4,000 targeted sequences and greatly reduces the amount of reagents required.
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A key component of the microdroplet PCR process is the generation of a high-quality primer library. Each element in the library consists of forward and reverse primers designed to amplify a targeted genomic interval. Primer pairs are combined at a concentration of 1.1 µM per primer (Fig. 1a) and reformatted using a flow-focusing nozzle as 8-picoliter (pl) primer pair droplets (primers are encapsulated in inert fluorinated carrier oil; Supplementary Fig. 1 ) 15 . Library elements are combined together such that each library element is represented by an equal number of droplets within the final primer library (Fig. 1a) . The resulting primer library is mixed and quality tested for primer pair droplet size and uniformity, as well as library element representation (Supplementary Fig. 2 ).
The genomic DNA template mixture ( Fig. 1) contains all of the components for PCR except for the primers and is prepared by fragmenting genomic DNA using DNaseI to produce 2-4 kb fragments (Fig. 1b) (Online Methods). On the microfluidic chip the template mixture is made into droplets and paired with primer pair droplets. The paired template and primer droplets enter the merge area on the microfluidic chip (Fig. 1c) at a rate of ~3,000 droplets per second. As the primer pair droplets (8 pl) are smaller than the template droplets (14 pl), they move faster through the channels until they contact the preceding template droplet. Field-induced coalescence of these droplet pairs 16 results in the two droplets merging to produce a single PCR droplet, which is collected and processed as an emulsion PCR reaction (Supplementary Fig. 3 ).
Validation phase: targeted sequences and DNA samples To validate the microdroplet PCR approach, we selected 47 genes distributed across the genome. Genes were selected to determine the extent to which a set of PCR primer pairs could be chosen to simultaneously amplify numerous loci with a broad spectrum of sequence compositions using a single set of reaction conditions (Supplementary Table 1 ). Local DNA context-such as repetitive elements, GC content and sequence variants-can affect the ability of PCR primer pairs to work. One major drawback of PCR sample preparation is that allelic imbalanced amplification (greater efficiency of amplification for one of the alleles) due to variants in primer sites is sometimes observed 17, 18 . This type of PCR bias results in variant basecalling errors, specifically, heterozygous sites are called homozygous. Although the majority of single-nucleotide polymorphisms (SNPs) shared among all populations have been discovered 19 and are taken into account during primer design, population-specific and rare variants are largely unknown.
To check for biases in the ability of primers designed to the reference genome to amplify genomic DNA from individuals of different ethnicities, we included three HapMap samples of European and three of African descent. We also selected ~60% of the targeted sequences from three ENCODE 20 intervals that were sequenced in five of the HapMap samples in our study as part of the HapMap Consortium 21 . This allowed us to compare the effect of allelic imbalanced amplification in intervals of the genome in which the majority of variation is known and can be accounted for during primer design, versus intervals that are less well annotated for variation.
Of the 47 genes targeted in the validation phase, 29 are from ENCODE 20 intervals, eight are members of the transient receptor potential ion (TRP) channel superfamily (included to test the ability to amplify and correctly align reads among family members with high nucleotide similarity), and the remaining 11 are candidates for deep venous thrombosis. Our primer design strategy (Online Methods) split the 435 exons of the 47 genes into 457 amplicons of varying sizes (119-956 bp) and GC content (24-78%) (Supplementary Tables 2  and 3 ). The full amplicon sequences constituted 172.2 kb. The exonic sequences comprised 75.9 kb (44%). It is important to note that the primer selection process did not attempt to minimize off-exon sequence, and thus if desired, the ratio of exon-off-exon sequences in the amplicons could be increased. The primer pairs were designed and put into production in a single pass; there was no redesign of failed primer pairs.
Specificity of amplification
Using the validation phase set of 457 primer pairs, we amplified the six DNA samples using both traditional singleplex and microdroplet (9) Paired droplets flow through the channel of the microfluidic chip to pass through a merge area where an electric field induces the two discrete droplets to coalesce into a single PCR droplet. The ~1.5 million PCR droplets are collected into a single 0.2 ml PCR tube. The collection of PCR droplets (PCR library) is processed in a standard thermal cycler for targeted amplification, followed by breaking the emulsion of PCR droplets to release the PCR amplicons into solution for genomic DNA (gDNA) removal, purification and sequencing.
A r t i c l e s PCR. After the PCR amplification step, all samples from the two methods were processed simultaneously through library creation and sequencing to ensure that any differences in the data were due to the amplification methods. Samples were labeled with a DNA barcode during the library preparation step. For each PCR method, all six bar-coded samples were run on a single lane (Online Methods). The two lanes generated equivalent amounts of sequence data with each sample having an average of 1.27 million reads passing quality filters ( Table 1) .
To determine how well the 457 primer pairs specifically amplified the targeted sequences, we calculated the percentage of filtered reads that mapped to a targeted amplicon. Considering all six samples, 82% and 73% of filtered reads successfully mapped to the full amplicon sequences for the traditional and microdroplet reactions, respectively ( Table 1) . Considering only uniquely mapping reads, 96% (231.69 Mb) of the traditional and 84% (202.15 Mb) of the microdroplet reads map back to the amplicons. Of these amplicon-mapped reads, after trimming primer sequences from the amplicons, which account for 12% of the total sequence, 91% of the traditional and 80% of the microdroplet reads mapped to targeted sequences. Of the reads mapping to the amplicons, 55.6% and 51.1% map to the exons for the traditional and microdroplet PCR, respectively. In the microdroplet PCR reaction, the ratio of input genomic DNA to amount of final PCR product is considerably greater than it is for traditional PCR (Online Methods), which may explain the ~15% difference between the two methods in reads that map off-target. Overall, these data demonstrate that the microdroplet PCR enrichment method generates a high proportion of target sequence to background sequences.
Coverage uniformity and reproducibility
Uniformity of sequence coverage across targeted sequences is important because it determines the average depth to which samples have to be sequenced to have optimal sensitivity for variant calling. If the coverage differs greatly across targeted bases then one has to sequence deeply to adequately cover underrepresented bases.
We initially examined how the base-by-base sequence coverage differs within individual amplicons. Visual inspection of coverage plots of individual targeted sequences (Fig. 2a) showed that there is typically a two-to threefold variation in the coverage depth per base sequence across the amplicon. A noticeable dip in sequence coverage occurs at the transition from the 36 th to 37 th base pair in the amplicon, which is likely due to more reads (36 bp in length) starting at base 1 compared to bases 2-5.
We next compared the coverage uniformity across all targeted bases for the six samples and the two PCR methods. The six samples had slightly different sequence yields in the traditional and microdroplet PCR methods (Table 1) . Therefore, we normalized the coverage (that is, divided the coverage of each base by the mean coverage of all targeted bases) so we could directly compare their coverage distribution plots (Fig. 3a,b) . We first determined the percentage of targeted bases with sequence coverage from one-fifth to five times the mean. For traditional PCR, this range encompassed 92.8% of all bases, of which 99.6% were covered by at least one read ( Fig. 3a and Supplementary Table 4 ). The microdroplet PCR showed similar results: 90.2% of all bases fell between one-fifth and five times the mean, and 99.8% of all targeted bases were covered by at least one read (Fig. 3b) . These results indicate that for studies using microdroplet PCR-amplified DNA and Illumina GA sequencing to an average depth of 25×, ~90% of the bases will be covered with ≥5 reads, and ~98% of all bases will be covered by at least a single read.
The consistency and reproducibility of coverage across targeted bases from sample to sample is of high importance for population studies. This is because coverage is directly correlated with accuracy in base calling, and moreover, the same bases need to be analyzed across numerous samples to perform sequence-based association studies. We compared the mean coverage of each amplicon between samples. Reproducibility was excellent between samples with high correlations of amplicon coverage within a PCR method (average Lin's concordance: r 2 = 0.88 traditional PCR, r 2 = 0.91 microdroplet PCR) (Fig. 4a,b) . On the other hand, coverage depth of specific A r t i c l e s amplicons between the two PCR methods varied (Fig. 4c,d ), most likely because of differences in PCR chemistry and cycling conditions. Interestingly, of the 457 amplicons there was only one that failed completely (no reads) in four samples with the traditional PCR. A different amplicon failed completely in three individuals with the microdroplet PCR. In both PCR methods, >99.6% of the amplicons were successful, defined as a mean coverage >5 reads. Coverage was similar for the European and African ancestry samples and for the targeted sequences in ENCODE and non-ENCODE intervals. These data demonstrate that microdroplet PCR results in consistent and reproducible coverage of targeted sequences.
Accuracy of sequence variant calls
We evaluated the accuracy of variant bases called in the PCR-amplified sequences for the six samples by comparison to HapMap genotypes for ~450 SNPs ( Table 2) . There were 2,424 comparisons for the traditional PCR across the six samples. Twenty-two of the comparisons were discordant for a consensus rate of 99.1% ( Table 2 ). The microdroplet PCR had the same consensus rate with 22 discordances out of 2,390 comparisons. In both PCR methods ~2.5% of the HapMap variant sites were uncalled, primarily owing to low coverage, poor mapping quality or the presence of neighboring variants. There was no observed difference in call rate or concordance between either the ENCODE and non-ENCODE intervals or between samples in the two ethnicity groups. Importantly, the two PCR methods were concordant with each other at all positions discordant with the HapMap. Of the 22 loci discordant with HapMap, the errors fell into three classes: (1) nine are homozygous reference genotypes with a HapMap homozygous alternate, (2) five are heterozygous genotypes with a HapMap homozygous reference and (3) eight are homozygous reference with a HapMap heterozygous genotype (Supplementary Table 5 ). Further examination of the discordant bases revealed that most class 1 errors are present in a single targeted sequence with a highly similar homolog in the genome. Our sequencing reports the reference alleles for the target, whereas HapMap calls the alternate alleles, which correspond to the fixed bases at those positions in the homolog. Inspection of the ENCODE traces revealed that the amplicons appeared to be amplifying both homologs, an observation supported by all individuals being heterozygous at the differing positions ( Supplementary  Fig. 4 ). Class 2 and 3 errors most likely represent missed heterozygous calls in the HapMap and sequence data, respectively.
Because allelic imbalanced amplification is a concern when performing PCR enrichment, we focused on the eight class 3 errors. A To estimate the false-positive rate, we analyzed the variants identified in the targeted genes in the ENCODE intervals that were sequenced in five of the samples as part of the HapMap project. A total of 1,122 variants at 442 positions were identified in these genes, of which 62 positions were not listed as variants in the HapMap data (Supplementary Table 6 ). Thirty-five of these positions are listed as variant in the National Center for Biotechnology Information SNP database, dbSNP, suggesting that they are not false positives. Of the 27 positions not listed in dbSNP, 12 have concordant calls between the traditional and microdroplet PCR for at least one sample, suggesting they may be true novel variants. The remaining 15 sites were either discrepant in the traditional but not in the microdroplet PCR (one position, three variant calls), or discrepant by one method and the position did not pass quality filters in the second method (14 positions, 15 variant calls). These analyses suggest that the false-positive rate of the sequence data is <1.6% (≤18 of 1,122 variant calls).
Scale-up phase: selection of target sequences
To efficiently perform population-based sequencing studies using next-generation sequencing platforms, it is important to be able to simultaneously examine large numbers of targeted sequences. In this next phase, we tested the ability of the microdroplet PCR to scale up to 3,976 primer pairs, which in total amplify 1. 
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amplicons by microdroplet PCR (Online Methods). The resulting amplified material was then divided into two aliquots and sequenced by both the Illumina GAII (short-read platform) and Roche 454 FLX (long-read platform). The Illumina run generated >10 million quality single-end reads with fractions similar to those observed in the validation phase of both total reads (76%) and uniquely mapped reads (79%) successfully mapped to the trimmed amplicon sequences ( Table 1 ). The Roche 454 run generated ~350,000 quality reads with ~94% of these mapping to the full amplicons. The larger fraction of Roche reads mapping to targets is likely because the microfluidic PCR-amplified DNA is not fragmented in the Roche 454 library preparation protocol, and therefore the nonspecific genomic DNA carryover from the amplification step (~2-4 kb in length) is too long to be efficiently used in library generation. These results indicate that even when simultaneously amplifying 3,976 targeted sequences, microfluidic PCR generates a high ratio of target sequence to background sequence.
Coverage uniformity and accuracy of variant calls
We evaluated the ability to uniformly capture the intended target across all 3,976 amplicons. Only one amplicon failed completely, resulting in zero mapping reads for both the Illumina and Roche 454 platforms. After trimming primer sequences, we enriched for a total of 1.35 Mb of sequence. On the Illumina platform, 99.8% of the bases were covered by ≥1 read, of which 96.6% fell within one-fifth and five times the mean coverage (Fig. 3c) . Furthermore, 90% of all amplicons had coverage at one-fifth the mean or greater for ≥95% of the bases. For 5× coverage, this increased to 98% of the amplicons. Coverage was lower for amplicons >70% GC content but was unaffected by amplicon length (Supplementary Fig. 5 ). The proportion of reads mapping to exons is closely proportional to the fraction of exonic sequences in the amplicons. The uniformity of coverage was slightly decreased when sequenced on the Roche 454 platform, with 93.7% of the bases covered by at least one read and 88.4% falling within one-fifth and five times the mean (Fig. 3c) . The lower coverage uniformity observed in the Roche 454 sequence results from sequencing the amplicon ends without shearing the input DNA in the library preparation. Therefore, the middle bases of short amplicons have high coverage, and the middle bases of longer amplicons receive little or no coverage (Fig. 2b) .
To examine accuracy, we compared variant bases called in the Illumina and Roche 454 sequences to 2,226 HapMap genotypes ( Table 3) . The Illumina sequence had a call rate of 99.3% with 26 discordant SNPs, whereas the Roche 454 sequence had a call rate of 92.3% with 31 discordant SNPs. The discrepant variants overlapped at 21 sites between the two sequence platforms and largely fell into the same error classes observed in the validation phase except for several discrepant Roche 454 SNPs that were present in homopolymer sequences (Supplementary Table 7) , consistent with previous observations 18 . The Roche 454 lower call rate is related to the low coverage bases in the middle of longer amplicons (Fig. 2b) . Overall these data show that increasing the number of amplicons in the microdroplet PCR reaction by almost an order of magnitude does not affect the resulting data quality.
DISCUSSION
Important parameters to consider when choosing an enrichment method for targeted sequencing include: uniformity of coverage of targeted sequences; the detection rate and calling accuracy of sequence variants; the efficiency of the enrichment over background sequences; universality of the capture method (fraction of genome that can be uniquely captured); and the multiplicity of the reaction (amount of sequence that can be targeted).
Compared with other enrichment methods, microdroplet PCR generates substantially greater uniform coverage of targeted sequences (Supplementary Discussion and Supplementary Table 8) . Importantly, the high uniformity of coverage results in a higher variant detection rate: microdroplet PCR (94.5%), solution-based hybridization (64-89%) 14 , molecular inversion probe (75%) 9 . The accuracy of called variant bases is currently high across all enrichment strategies. Likewise the proportion of reads mapping to targeted sequences is similar (~65%) across the different enrichment methods 9, 14 .
Microdroplet PCR is a universal method allowing for the unique capture of most sequences, even those highly similar to other sequences in the genome. By anchoring a primer in the divergent portion of a homologous sequence or in an adjacent unique region, almost any interval can be specifically targeted. In contrast, hybridization-based methods cannot capture individual repetitive elements or homologous exons.
For many population studies it will be desirable to simultaneously examine large numbers of targeted sequences. We have demonstrated the ability of microdroplet PCR to enrich for ~4,000 targeted sequences in a single tube per sample. We are working toward scaling this to 20,000 targets (~7.5 Mb, ~1/10 th the exome) using an expanded content format with five sets of primers in each droplet (Online Methods) and no other changes to the workflow. The molecular inversion probes method has been used to enrich for 13,000 targeted sequences with high performance 9 and the solutionbased hybridization approach has shown the ability to target 22,000 sequences simultaneously 14 . Therefore, the multiplicity of the targets and the scalability of these methods enable a large number of samples to be examined in population studies. Recently an array-based capture has been employed to target 26.6 Mb of coding exons of 12 individuals with similar mapping efficiency as that of solution-based hybridization 22 . Although the approach has excellent concordance and uniformity, array-based capture is difficult to scale for population studies in individual laboratories.
The microdroplet PCR process proved to be extremely efficient, with >99.6% of all amplicons being successful (mean coverage >5 reads) and with highly reproducible amplification of targeted sequences between samples. Allelic amplification bias resulted in surprisingly few known variants to be incorrectly called, further attesting to the robustness of the process. An improved ability to remove nonspecific genomic DNA carryover (Online Methods) would increase the enrichment observed on short-read sequence platforms by ~15% to that observed on the Roche 454. The requirement for 7.5 µg of starting DNA used in this study limits the applicability of microdroplet PCR for samples with limited quantities. Although optimization has reduced the current requirement to 2 µg, we are working on further improvements to reduce the amount of required starting material to nanogram quantities of DNA (Supplementary Discussion). 
ONLINE METHODS
Microdroplet-based PCR workflow: primer library generation. Preparation of a high-quality primer library is achieved through several steps. Primer pairs are designed and synthesized to amplify the targeted genomic regions. The forward and reverse primers for each amplicon are combined at a concentration of 1.1 µM per primer (Fig. 1a) and reformatted as 8-pl primer pair droplets by using a flow-focusing nozzle (Supplementary Fig. 1 ) in a microfluidic chip 15 . Library elements are tested for droplet size and uniformity ( Supplementary  Fig. 2 ) and mixed together such that each library element is represented by an equal number of droplets within the primer library (Fig. 1a) .
Primer library quality control. The method for determining library element representation consists of measuring the total volume of primer solution that is made into droplets from each library element and measuring the distribution of droplet sizes present in each library element (Supplementary Fig. 2 ). These two measurements are made by using a flow sensor and a stroboscopic imaging system. The time integral of the measured infusion rate on the flow sensor provides a measure of the total volume of primer solution made into droplets for each library element. The stroboscopic imaging system collects images at a rate of 10 per second and each image contains roughly 20 droplets. This sampling of roughly 200 droplets per second of the 8,000 per second generated is used to measure a representative distribution of the droplet volumes for each library element. The pass criteria consist of all library elements being represented, with >90% of the droplets between 7.0 and 9.0 pl. A bar graph of the total count of droplets for each library element from the stroboscopic imaging system provides a snapshot of the uniformity achieved.
The primer library for the 3,976-amplicon library was made from 11 separate 384-well plates in a process whereby an equal number of droplets was made from each well on a given plate and stored in a collection vial for that plate. The 11 collection vials were then mixed and an equal volume of emulsion was transferred from each collection vial into a pooling vial; with the exception of the last vial, which had a proportionally smaller volume transferred as it contained fewer library elements. Hence, the appropriate qualitycontrol metric is the droplet count for each library element that went into a given collection vial and 11 separate droplet count graphs were generated; Supplementary Fig. 2d being representative. In the case of the 457 library, all library elements were collected directly into the final pooling vial and the quality control on the number of droplets was appropriately conducted on all 457 library elements (Supplementary Fig. 2b ). The histogram of droplet-size distribution (Supplementary Fig. 2c) is for the pooled library containing all library elements.
Genomic DNA fragmentation and nick translation. Genomic DNA is fragmented using DNase I to produce 2-4 kb fragments and nick translated to incorporate biotinylated nucleotides into the genomic DNA fragments. Fragmentation of the genomic DNA to 2-4 kb allows for optimal template size for performing PCR in droplets. Incorporation of biotinylated nucleotides during the nick-translation step allows the genomic DNA to be removed during the genomic DNA removal step to reduce the number of genomic DNA fragments entering into the construction of the Illumina GAII and Roche 454 sequencing libraries.
The genomic DNA samples are processed on ice: 7.8 µg of genomic DNA in 25 µl nuclease-free water (Fisher), 37.5 µl of NEBuffer 2 (New England Biolabs (NEB)), 37.5 µl of a mixture of 1 mM each dCTP, dGTP, dTTP (NEB), 18.75 µl of 0.4 mM Biotin-14 dATP (Invitrogen), 211.25 µl nuclease-free water, 7.5 µl DNA polymerase I (10 units/µl) (NEB), 37.5 µl of DNase I (NEB) at a concentration determined by titration to achieve a 2-to 4-kb size distribution. The genomic DNA fragmentation reaction mix is incubated at 15 °C for 90 min and the reaction stopped by adding 37.5 µl of 0.5 M EDTA, pH 8.0 (Ambion). The DNA is purified over a Qiagen MinElute PCR purification column (Qiagen) using the manufacturer's recommended conditions except for eluting with 13 µl of 10 mM Tris-Cl, pH 8.5.
Genomic DNA template mix. 9.3 µl of the purified genomic DNA fragmentation reaction was added to 2.5 µl 10× high-fidelity buffer (Invitrogen), 1.6 µl of MgSO 4 (Invitrogen), 0.8 µl 10 mM dNTP (NEB), 4.0 µl Betaine (Sigma), 4.0 µl of RDT Droplet Stabilizer (RainDance Technologies), 2.0 µl dimethyl sulfoxide (Sigma) and 0.8 µl 5 units/µl of Platinum High-Fidelity Taq for a final volume of 25 µl.
RDT 1000: merge. PCR droplets are produced by combining a single droplet from the primer library with a single genomic DNA template droplet (Supplementary Fig. 3) . To achieve this, 20 µl of the Genomic DNA Template Mix is delivered to a microfluidic chip where it generates 14-pl template droplets at a rate of 3,000 droplets s -1 (Supplementary Fig. 3b) . In a separate channel primer library droplets are delivered onto the same chip ( Supplementary  Fig. 3a ) and spaced to enter the channel carrying the genomic DNA template droplets at a one-to-one ratio (Supplementary Fig. 3c) . As the primer library droplets are smaller than the template droplets, they move faster and catch up to the genomic DNA template droplets so that they enter the merge area on the chip (Supplementary Fig. 3d ) as droplet pairs. In the merge area, the two droplets (template and primer pair droplets) coalesce in the presence of an external electric field 16 to produce a single PCR droplet. The fidelity of the microfluidic flow enables one to set up individual PCR reactions at a rate of 3,000 per second. Over the period of roughly 10 min the 20-µl genomic DNA template mix is processed into greater than 1.5 million PCR droplets (Supplementary Fig. 3e ). The collection of PCR droplets represents essentially equal numbers of individual reactions from each library element. The PCR droplets are collected in a single standard PCR tube (Axygen) for thermal cycling and further processing (Supplementary Fig. 3f ). The whole process can be viewed in Supplementary Movie 1 depicting the delivery of the primer pair droplets and the formation of the genomic DNA template droplets that pair together in a 1:1 ratio and merge into PCR droplets, which are collected for downstream highly parallel amplification of over a million singleplex PCR reactions. Breaking emulsion. After amplification the PCR droplets are broken to release the PCR products from each individual emulsion reaction droplet. An equal volume of RDT 1000 Droplet Destabilizer (RainDance Technologies) is added to the collected PCR emulsion, the tube is vortexed for 15 s and then spun in a microcentrifuge for 10 min. A Gel-Loading Aerosol-Barrier Tip (Fisher Scientific) is used to remove the oil from below the aqueous phase.
Genomic DNA removal. 110 µl of streptavidin beads (NEB, S1420S) in a 1.5 ml microcentrifuge tube are spun briefly in a microcentrifuge and placed on a magnetic separation rack (NEB, S1506S) for 30 s; the supernatant is removed and discarded. The beads are resuspended in 110 µl of binding buffer (0.5 M NaCl, 20 mM Tris-HCl (pH 7.5), 1 mM EDTA) by vortexing, briefly spun in a microcentrifuge and placed on a magnetic separation rack for 30 s; the supernatant is removed and discarded. The washed beads are resuspended in 110 µl of binding buffer and 50 µl of the beads are added to the broken amplicon emulsion. The beads are vortexed and then incubated for 10 min rotating on a Barnstead Labquake Tube Rocker. The beads are placed in a magnetic separation rack for 30 s and the supernatant transferred to a new 1.5 ml microcentrifuge tube. 50 µl more of the beads are added to the supernatant followed by vortexing and placement on the magnetic separator rack for 30 s. The supernatant was removed to a new 1.5 ml microcentrifuge tube. The DNA is then purified over a Qiagen MinElute PCR purification column (Qiagen) using the manufacturer's recommended conditions and eluted using 11 µl of Elution Buffer (10 mM Tris-Cl, pH 8.5). 1 µl of the eluant is run on an Agilent Bioanalyzer using the DNA 1000 Kit (Agilent, 5067-1504) to determine the yield for the amplicons. Typical yields originally were 100-300 ng. With improved conditions the typical yields are currently 200-600 ng. Data analysis: Illumina GAII mapping, amplicon efficiency and coverage uniformity. All samples sequenced on the Illumina GAII were processed through the Illumina pipeline v1.3 using default parameters. High-quality filtered reads were mapped to the entire human genome (hg18) reference sequence (NCBI Build 36.1), using Maq v0.71 (ref. 26) default parameters except for insert size (-a 150) and mismatches (-n 3). Uniquely mapping reads were considered reads with a mapping quality score ≥20 corresponding to a 1% chance of being incorrectly mapped. The coverage uniformity analysis calculated coverage at the predicted amplicons after trimming primer sequences. Mean amplicon coverage and total coverage plots were produced using custom scripts and the statistics package R. None of the 457 amplicons in the validation phase failed (mean coverage <1) across all six samples. For traditional PCR there were four failures of a single amplicon across the six samples; this amplicon performed well for microdroplet-based PCR. Likewise a different amplicon failed for three of the six microdroplet-based amplified samples but performed well in the traditional PCR.
Illumina GAII, variant detection and quality assessment. Mapped reads from the coverage analysis were used for variant detection using default parameters of the Maq SNP calling algorithm except for the following parameters (-w 10, -N 2, -W 2). Variants were additionally filtered using the Maq variant consensus score. This value was empirically derived for the validation and scale-up phases by plotting the variant call rate against the consensus score and selecting the highest score just before a drop in call rate. The cutoff for the validation phase (paired-end reads) was set at 30. The scale-up phase (single-end reads) was filtered at a score of 50. The need to use a higher Maq quality cutoff for single versus paired-end reads is well characterized 6 .
A combined set of both HapMap phase II and III genotypes were used for comparisons, the forward strand calls were downloaded from the HapMap website (http://www.hapmap.org/). Concordance was calculated by the number of single nucleotide variants called the same between the HapMap and sequence data divided by the number of single nucleotide variants in the HapMap data for which the sequences data had a Maq variant consensus greater than the derived threshold as well as coverage of 5 reads or more at the base. Bases with a consensus score less than the threshold or fewer than 5 reads covering the site were masked as no calls and were counted against the variant detection rate score but not the concordance rate. Calls were considered discordant regardless of the type of discordance, for example, an AB to AA error affected the concordance score the same as an AA to BB error.
Roche 454, mapping and variant detection and quality assessment. Data from the sequencing run on the 454 FLX was processed using 454's standard data analysis software. For the amplicon amplification efficiency and coverage uniformity analyses high-quality filtered reads were mapped to the predicted amplicon sequences, which were extracted from the hg18 reference sequence (NCBI Build 36.1), using the default parameters of the command line version of the Newbler module GS Mapper (version 2.0.00.20-64).
Prior to performing variant detection analysis the high-quality filtered reads were mapped to the entire human genome reference sequence (hg18). Reads that aligned to one of the predicted amplicon sequences in the coverage analysis but matched to a homologous region when mapped to the entire human genome were removed before variant detection. Variants were detected using Atlas-SNP (version was 0.9.9.2) (http://code.google.com/p/atlas-snp/) with default parameters. Variant probability scores, which measure the probability of a substitution error at the SNP site were generated using the atlas_snp_ evaluate.rb script with an estimated substitution error rate of 0.0008 and an estimated SNP rate of 0.001. Variant sites were called at positions containing 5 or more reads, sites with <5 reads were marked as no calls. Heterozygote positions were called when the alternate allele was present in 20-80% of the reads and contained an atlas probability score of greater than 1 × 10 −5 . Probable heterozygotes with a probability score of less than 1 × 10 −5 were deemed unreliable and marked as a no-call site. Variants were then compared to the HapMap phase II and III genotypes and variant detection rate and concordance rate were calculated in the same manner described above for the Illumina GAII sequence data. 
